NRCHealthcare · Health Information Services

NRC Stock Forecast: NRC Health Price Predictions for 2026-2027

Last close, 12 Oct 2026

$20

+0.39% on the day

The 1 Wall Street analysts covering NRC Health hold a median 12-month price target of $26 — +27.4% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 90 of 100 as at 12 Oct 2026 — among the strongest tenth. Here, the model and the Street point the same way.

Market cap

$449.7M

Ticker Nerd rank

90 / 100

Median analyst target

$26

Analysts covering

Revenue$35.4M+4.0% y/y

Operating income−$3.2M

Net income−$3.3M

Free cash flow$62K

Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown

Total return, dividends reinvested

−1.8%

−2.6%

YTD

+11.8%

+85.0%

From 52W high

−9.6%

From 52W low

+86.0%

$11

$23

52-week range, adjusted closes · the dot is the last close

Ticker Nerd rank

NRC stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores NRC Health on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 12 Oct 2026

90 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Momentum

Accruals

Quality

Volatility

Revisions

Value

Issuance

Size

Growth

Momentum (91): The shares have been drifting up relative to others.

Growth (35): Sales and profits are flat, shrinking, or growing more slowly than they were.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

NRC stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on NRC, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says1 analysts

1 Buy0 Hold0 Sell

Low $26Median $26High $26

The green dot is the last close — the median target sits +27.4% from it.

Recent analyst actionsNewest first

Date	Firm	Action	Rating	Target
29 July 2026	Citizens	Maintains	Market Outperform	$23 → $26
22 June 2026	Citizens	Initiates	Market Outperform	$23
22 June 2026	Citizens	Initiates	Market Outperform	—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. NRC appears on the weeks it earns a place.

Performance

NRC vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 12 Oct 2026, NRC Health returned +85.0% against +20.4% for the S&P 500, dividends included.

NRC vs S&P 500, last 12 monthsTotal return, rebased to 100

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

NRC analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year

Analysts raising

Analysts cutting

Fundamentals

NRC Health (NRC) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation

Trailing P/E: 84.7×
Price / sales: 3.2×
Price / book: 68.7×
EV / EBITDA: 20.0×

Growth & margins

Revenue growth (YoY): 4.0%
Earnings growth (YoY): −44.3%
Gross margin: 61.7%
Operating margin: −0.2%
Net margin: 4.2%

Returns & dividend

Return on equity: 42.0%
Return on assets: 8.1%
Dividend yield: 3.1%

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

NRC Health (NRC) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

NRC Health has a market value of $449.7M and an enterprise value of $533.7M.
Revenue in the twelve months to 30 June 2026: $140.0M. The latest quarter grew 4.0% year on year.
Net income over the same four quarters: $5.9M, a 4.2% net margin.
Diluted earnings per share, trailing twelve months: $0.25.
Free cash flow in the twelve months to 30 June 2026: $21.6M.
NRC Health spent $18.8M on share buybacks and $12.7M on dividends in the twelve months to 30 June 2026.
Shares outstanding: 22.1M.
Trailing P/E: 84.7×; forward P/E: 19.4× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 3.14%, paying out 250% of earnings.
NRC Health employs 357 people — $392K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 12 Oct 2026

Data provided by Twelve Data

Peers

NRC vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelHealth Information Services

Company	Market cap	TKN rank
NRCNRC Health	$449.7M	90
EVHEvolent Health, Inc.	$474.5M	61
CTEVClaritev Corp.	$412.3M	64
CARLCarlsmed, Inc.	$401.8M	33
SLPSimulations Plus, Inc.	$374.2M	—
WEAVWeave Communications, Inc.	$590.4M	81
SOPHSOPHiA GENETICS SA	$605.7M	55

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own NRC Health — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest NRC news & analysis

NRC Health Trades at a Discount: Should You Buy, Sell or Hold?

Zacks Investment Research · 28 Sept 2026positive

Zacks Investment Research published an analysis noting that NRC Health is trading at a discount while highlighting its rising recurring contract value, expanding sales pipeline, and AI-enabled tools. The report points to these factors as supporting revenue visibility and potential margin improvement.

Why it matters — An NRC watcher would care because the piece points to the company's recurring revenue growth, pipeline expansion, and AI capabilities as drivers of revenue visibility and potential margin improvement.

New Momentum in the Nuclear Fuel Chain

ETF Trends · 14 Sept 2026positive

The article highlights growing momentum in the nuclear fuel chain, noting that the nuclear renaissance requires a fuel supply infrastructure capable of supporting reactor development companies' ambitions.

Why it matters — A strengthening nuclear fuel chain suggests increased demand for uranium fuel and related services, which are central to the nuclear sector broadly.

Mercy Earns National Honor for Excellence in Patient Experience

PRNewsWire · 1 Sept 2026positive

Mercy, one of only three large U.S. health systems, received NRC Health's 2026 Excellence in Patient Experience Award, marking its fifth consecutive year earning the national honor.

Why it matters — The recognition reflects ongoing validation of NRC's patient-experience measurement and award program within large health systems.

NRC Health Announces 2026 Award Winners Recognizing Excellence Across Healthcare

Business Wire · 1 Sept 2026positive

NRC Health announced the winners of its 2026 awards program, recognizing hospitals, health systems, medical groups, and specialty providers for excellence in patient experience, consumer loyalty, innovation, and patient-centered care.

Why it matters — The annual awards highlight NRC Health's role in measuring and promoting healthcare consumer loyalty and patient experience, reinforcing its brand and industry visibility.

NRC Down 8% Despite Q2 Earnings Rising Y/Y on TRCV Growth

Zacks Investment Research · 3 Aug 2026neutral

NRC Health's shares fell 8% even as its Q2 earnings per share rose year over year, driven by higher recurring contract value and strong Governance Institute bookings, partly offset by elevated operating expenses.

Why it matters — NRC watchers would see this as a mixed signal: the underlying business grew on recurring revenue and bookings strength, but the stock declined and rising operating expenses weighed on results.

FAQ

Frequently asked questions about NRC stock

What is the NRC stock price forecast for 2026-2027?

The 1 Wall Street analysts covering NRC Health have a median 12-month price target of $26, with estimates ranging from $26 to $26. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is NRC stock a buy right now?

Of the 1 analysts covering NRC Health, 1 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks NRC Health 90 out of 100 across roughly 4,600 US stocks as at 12 Oct 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank NRC?

As at 12 Oct 2026, NRC Health ranks 90 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Momentum (91 of 100).

Will NRC stock go up?

No one can know that. What the data says: the median 12-month target from 1 analysts implies +27.4% from the last close, and Ticker Nerd's factor model ranks NRC Health 90 out of 100 as at 12 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the NRC stock forecast for 2030?

No analyst covering NRC Health publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for NRC are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $26 to $26 over the next 12 months.

How has NRC stock performed over the past year?

NRC Health returned +85.0% over the 12 months to 12 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.

What does NRC Health do?

What is the latest news on NRC?

The most recent item we track (Zacks Investment Research, 28 Sept 2026): "NRC Health Trades at a Discount: Should You Buy, Sell or Hold?". Zacks Investment Research published an analysis noting that NRC Health is trading at a discount while highlighting its rising recurring contract value, expanding sales pipeline, and AI-enabled tools. The report points to these factors as supporting revenue visibility and potential margin improvement.

Company

About NRC Health.

NRC Health is a healthcare experience management company headquartered in Lincoln, Nebraska. It provides software, analytics, and recurring service programs that help hospitals, health systems, medical groups, and other care organizations understand and improve the experiences of patients, consumers, and employees. The company’s current offerings include patient experience measurement, consumer and market insights, online reputation management, employee engagement tools, and governance support for healthcare leaders. NRC Health also delivers benchmarking, segmentation, and workflow solutions designed to help organizations track perceptions, identify service gaps, and align care delivery with community needs. Its platform is used across the healthcare industry to support patient engagement, loyalty, workforce experience, and performance improvement through data-driven insight and human-centered care.

CEO Mr. Trent S. Green · 357 employees · United States · https://www.nrchealth.com